| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |